BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03392246-completion@plaintrial.com
DTSTAMP:20261030T095221Z
DTSTART;VALUE=DATE:20261230
SUMMARY:A Phase 2 Study of Osimertinib in Combination With Selumetinib in E
 GFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer — estimated comple
 tion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT03392246
URL:https://plaintrial.com/trial/NCT03392246
END:VEVENT
END:VCALENDAR